A new study, led by Professor John Deanfield from University College London (UCL), reveals that the anti-obesity medication ...

A new medical study published this month suggests yes — with some key factors to keep in mind. Ozempic’s long-term impact.

Semaglutide injections effectively support weight loss by regulating appetite and glucose levels, offering benefits for ...

Researchers found that patients with obesity had an average weight loss of 12.9% with semaglutide vs 5.6% with liraglutide ...

A survey reveals 25% of adults are considering using weight loss drugs without a prescription, raising concerns about safety ...

In the last couple of days at the European Association for the Study of Diabetes (EASD) 60th Annual Meeting 2024, the ...

The European Medicines Agency's Committee for Medicinal Products for Human Use has recommended an update to Novo Nordisk’s ...

Paid Advertisement Millions of people throughout the world battle to stay at a healthy weight. With obesity rates rising and linked health conditions such as type 2 diabetes, cardiovascular ...

Talk about semaglutide—the drug better known by brand names like Ozempic, Wegovy, and Rybelsus—is everywhere these days. But ...

At EASD 2024, clinical trial results from the Novo Nordisk’s COMBINE programme on IcoSema were presented on 11 September.

UNSW medical researchers say more Australians with type 2 diabetes need to be offered add-on medications that would better ...

Becton, Dickinson and Company's tests, which were approved in May by the FDA for patients' use in clinical settings, offer an alternative to traditional pelvic exams.